P3Development of a 6-gene qPCR RUO-validated assay as a predictive biomarker for response of vantictumab (OMP-18R5; anti-frizzled) in HER2- breast cancer patients Chun Zhang1, Gilbert O’Young1, Katarina Wikstro

First Page		Document Content
Date: 2015-12-11 14:24:30		P3Development of a 6-gene qPCR RUO-validated assay as a predictive biomarker for response of vantictumab (OMP-18R5; anti-frizzled) in HER2- breast cancer patients Chun Zhang1, Gilbert O’Young1, Katarina Wikstro Add to Reading List Source URL: posters.omed.s3.amazonaws.com Download Document from Source Website File Size: 567,45 KB Share Document on Facebook